Please enter keyword
OK
Please enter keyword
OK
Gene Editing
By species
By technologies
CRISPR/EGE™
ESC/HR
Transposon
Other services
By strategies
Animal & Cell Models
Humanized animal models
Immune checkpoint humanized mice
Cytokine humanized mice
GPCR humanized mice
Other humanized mice
KO mouse models
Drug target knockout mice
Other knockout mice
Tool mice
Cre mice
Reporter mice
Other tool mice
Immunodeficient mice/rats
B-NDG series immunodeficient mice
Other immunodeficient mice/rats
Cell lines
Humanized cell lines
Mouse derived cell lines
Reporter cell lines
Other cell lines
Aged mice
Disease mouse models
Oncology Disease
Autoimmune Disease
Nervous System Disease
Metabolic Disease
Orthopedic Disease
Ophthalmic Disease
Cardiovascular diseases
Urinary System Disease
Surgical disease
Rare Disease
Pharmacology Services
Therapeutic area
Oncology
Metabolic diseases
Autoimmune diseases
Inflammatory diseases
Types of services
In vivo pharmacology
Ex vivo pharmacology
In vitro pharmacology
Pharmacokinetics (PK) assays
Pathological/Toxicological assays
Model/method development
Integrated solution
Molecule type
Small molecule
Peptide/protein
Antibody
XDC
Tumor vaccine
Gene therapy
Cell therapy
Technology
In vivo
Ex vivo
In vitro
Resources & Activities
Technical support
Courses
Brochure
Q & A
Publications
News & events
News
Events
Other Services
Microbial detection
Pathogen
Parasite
Virus
Other
Animal Breeding
Animal Cryopreservation
Animal Rederivation
About Us
Biocytogen animal center
Certifications
Join us
Contact us
Biocytogen
English
|
Chinese
English
Chinese
Home
Resources&Activities
Technical support
Resources
Poster
Resources
Webinar
Resources
Technical Q & A
Publications
Poster
Case studies
Brochure
AACR2024: A novel humanized CD16A model to evaluate efficacy of human antibody therapeutics in triggering ADCC
AACR2024: Development and validation of humanized HLA mouse model platforms for preclinical evaluation of novel peptide vaccines
AACR2024:Generation of a novel severely immunodeficient Sprague Dawley rat model for xenograft studies
AACR2024: A novel humanized NKP46 mouse model to support xenograft studies evaluating NK cell-based cancer immunotherapies
AACR2024: Establishment of a humanized IL5/IL5RA mouse model to evaluate modulators of eosinophilic inflammation in vivo
AACR2024: TIL analysis demonstrates different mechanisms underlying PD-1 resistance in animal models
AACR2024: Generation and validation of a novel humanized IL-31/IL-31RA/OSM/OSMR mouse model
AACR2024: Validation of humanized TL1A mice for advancing preclinical research
AACR2024:Development of humanized VEGFA models to assess preclinical efficacy of novel therapeutics in vivo
1
2
3
4
5
6
GO
More